| 778898 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Target engagement of the first-in-class CXCR7 antagonist ACT-1004-1239 following multiple-dose administration in mice and humans |
2021-12-01 |
10.1016/j.biopha.2021.112363 |
Huynh Christine, Brussee Janneke M., Pouzol Laetitia, Fonseca Marlene, Meyer zu Schwabedissen Henriette E., Dingemanse Jasper, Sidharta Patricia N. |
| 778897 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Saroglitazar and Hepano treatment offers protection against high fat high fructose diet induced obesity, insulin resistance and steatosis by modulating various class of hepatic and circulating lipids |
2021-12-01 |
10.1016/j.biopha.2021.112357 |
Sarkar Soumalya, Kumari Deepika, Gupta Sonu Kumar, Sharma Vipin, Mukhi Sumedha, Kamboj Parul, Sasibhushan Vedula, Rai Rajiva Kumar, Jatavallabhula Sastry Lakshminarayana, Mahajan Dinesh, Kumar Yashwant, Kumar Ajay, Dikshit Madhu |
| 778896 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
The endocytic pathway of Pt nanoclusters and their induced apoptosis of A549 and A549/Cis cells through c-Myc/p53 and Bcl-2/caspase-3 signaling pathways |
2021-12-01 |
10.1016/j.biopha.2021.112360 |
Zhao Lingyun, Li Hongyun, Huang Xin, Liu Ting, Xin Yi, Xiao Zhongqing, Zhao Wenfei, Miao Shaoyi, Chen Jing, Li Zengbei, Mi Yang |
| 778895 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Centrosomal-associated Proteins: Potential therapeutic targets for solid tumors? |
2021-12-01 |
10.1016/j.biopha.2021.112292 |
Luan Yi, Li Mingli, Zhao Yi, Li Qianqian, Wen Jia, Gao Siqi, Yang Yang |
| 778894 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Overcoming PLK1 inhibitor resistance by targeting mevalonate pathway to impair AXL-TWIST axis in colorectal cancer |
2021-12-01 |
10.1016/j.biopha.2021.112347 |
Solanes-Casado Sonia, Cebrián Arancha, Rodríguez-Remírez María, Mahíllo Ignacio, García-García Laura, Río-Vilariño Anxo, Baños Natalia, de Cárcer Guillermo, Monfort-Vengut Ana, Castellano Víctor, Fernández-Aceñero Maria Jesús, García-Foncillas Jesús, del Puerto-Nevado Laura |
| 778893 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Bioactive components and mechanisms of poplar propolis in inhibiting proliferation of human hepatocellular carcinoma HepG2 cells |
2021-12-01 |
10.1016/j.biopha.2021.112364 |
Liu Hui, Li Junya, Yuan Wenwen, Hao Shengyu, Wang Meng, Wang Fei, Xuan Hongzhuan |
| 778892 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Rapamycin attenuates PLA2R activation-mediated podocyte apoptosis via the PI3K/AKT/mTOR pathway |
2021-12-01 |
10.1016/j.biopha.2021.112349 |
Chiou Terry Ting-Yu, Chau You-Ying, Chen Jin-Bor, Hsu Hsiang-Hao, Hung Shao-Pei, Lee Wen-Chin |
| 778891 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Cervical cancer progression is regulated by SOX transcription factors: Revealing signaling networks and therapeutic strategies |
2021-12-01 |
10.1016/j.biopha.2021.112335 |
Paskeh Mahshid Deldar Abad, Mirzaei Sepideh, Gholami Mohammad Hossein, Zarrabi Ali, Zabolian Amirhossein, Hashemi Mehrdad, Hushmandi Kiavash, Ashrafizadeh Milad, Aref Amir Reza, Samarghandian Saeed |
| 778890 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Corrigendum to: ‘Rituximab prevents and reverses cardiac remodeling by depressing B cell function in mice’ [Biomed. Pharmacother. 114 (2019) 108804] |
2021-12-01 |
10.1016/j.biopha.2021.112348 |
Ma Xiao-Lei, Lin Qiu-Yue, Wang Lei, Xie Xin, Zhang Yun-Long, Li Hui-Hua |
| 778889 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Betaine prevents and reverses the behavioral deficits and synaptic dysfunction induced by repeated ketamine exposure in mice |
2021-12-01 |
10.1016/j.biopha.2021.112369 |
Chen Shao-Tsu, Hsieh Chung-Pin, Lee Mei-Yi, Chen Liao-Chen, Huang Chien-Min, Chen Hwei-Hsien, Chan Ming-Huan |
